Bio-Rad Laboratories, Inc. (NYSE:BIO.B - Get Free Report)'s share price dropped 17.3% during mid-day trading on Monday . The company traded as low as $279.91 and last traded at $279.91. Approximately 400 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 1,193 shares. The stock had previously closed at $338.55.
Bio-Rad Laboratories Stock Performance
The stock has a 50 day simple moving average of $314.98 and a 200 day simple moving average of $313.58. The company has a quick ratio of 4.89, a current ratio of 6.57 and a debt-to-equity ratio of 0.13. The company has a market cap of $7.98 billion, a price-to-earnings ratio of -27.02 and a beta of 0.70.
Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) last released its quarterly earnings results on Thursday, February 15th. The company reported $3.10 earnings per share for the quarter. Bio-Rad Laboratories had a negative net margin of 12.37% and a positive return on equity of 3.59%. The business had revenue of $681.18 million during the quarter.
Bio-Rad Laboratories Company Profile
(
Get Free Report)
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Featured Articles
Before you consider Bio-Rad Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bio-Rad Laboratories wasn't on the list.
While Bio-Rad Laboratories currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
